Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARROW, INC. Director's Dealing 2020

May 23, 2020

31774_dirs_2020-05-22_8a7938bf-aff3-4914-a1fe-2353df452a2f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2020-05-14

Reporting Person: Opaleye Management Inc. (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, $0.001 par value 2480500 Indirect
Common Stock, $0.001 par value 118600 Indirect

Footnotes

F1: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. ("Opaleye") may be deemed to beneficially own the securities owned directly by the Fund.

F2: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.